These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20596118

  • 21. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS, Cruz LS, Domingues GS, Souza CA.
    Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
    [Abstract] [Full Text] [Related]

  • 22. [New prospects in diagnosis and treatment of heart failure].
    Pfister U, Lerch R, Hess OM.
    Praxis (Bern 1994); 2002 Jan 30; 91(5):177-80. PubMed ID: 11865776
    [No Abstract] [Full Text] [Related]

  • 23. Implications of heart failure drug trials: COMET, CHARM, EPHESUS.
    Hiestand B, Abraham WT.
    Rev Cardiovasc Med; 2005 Jan 30; 6 Suppl 2():S4-11. PubMed ID: 15891699
    [Abstract] [Full Text] [Related]

  • 24. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN, Mareev VIu, Skvortsov AA.
    Ter Arkh; 2008 Jan 30; 80(9):5-12. PubMed ID: 19555028
    [No Abstract] [Full Text] [Related]

  • 25. The role of aldosterone blockade in end-stage renal disease.
    Pitt B, Saran R.
    Cardiology; 2009 Jan 30; 114(1):30-1. PubMed ID: 19342856
    [No Abstract] [Full Text] [Related]

  • 26. [Combination therapy of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers].
    Minami J, Ishimitsu T, Matsuoka H.
    Nihon Rinsho; 2005 Mar 30; 63 Suppl 3():194-200. PubMed ID: 15813067
    [No Abstract] [Full Text] [Related]

  • 27. Hyperkalaemia: again.
    Gross P, Pistrosch F.
    Nephrol Dial Transplant; 2004 Sep 30; 19(9):2163-6. PubMed ID: 15299094
    [No Abstract] [Full Text] [Related]

  • 28. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 30; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 29. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
    McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J, Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators.
    Circ Heart Fail; 2008 May 30; 1(1):17-24. PubMed ID: 19808266
    [Abstract] [Full Text] [Related]

  • 30. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R, Borelli G, Coceani M, Zingaro S, Barison A, Morelli I, Rondinini L.
    J Clin Pharm Ther; 2008 Aug 30; 33(4):349-56. PubMed ID: 18613852
    [Abstract] [Full Text] [Related]

  • 31. [Chronic systolic heart failure - dosing recommendations at beginning and end of treatment].
    Zugck C, Remppis A, Katus HA, Frankenstein L.
    Ther Umsch; 2008 Oct 30; 65(10):585-92. PubMed ID: 18821517
    [Abstract] [Full Text] [Related]

  • 32. Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism.
    Poggio R, Grancelli HO, Miriuka SG.
    Postgrad Med J; 2010 Mar 30; 86(1013):136-42. PubMed ID: 20237007
    [Abstract] [Full Text] [Related]

  • 33. [Medical treatment of hypertension--what treatment for what patients?].
    Zidek W, Tepel M, van der Giet M.
    MMW Fortschr Med; 2004 May 27; 146(22):31-4. PubMed ID: 15373106
    [Abstract] [Full Text] [Related]

  • 34. [How is catecholamine therapy carried out in heart failure?].
    Reek S.
    Dtsch Med Wochenschr; 2002 Oct 04; 127(40):2087-8. PubMed ID: 12373645
    [No Abstract] [Full Text] [Related]

  • 35. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep 10; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract] [Full Text] [Related]

  • 36. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP.
    Cardiol Rev; 2006 Sep 10; 14(2):81-7. PubMed ID: 16493245
    [Abstract] [Full Text] [Related]

  • 37. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C, Kosa M, Schröder J, Kirch W.
    Dtsch Med Wochenschr; 2010 May 10; 135(3):98. PubMed ID: 20077385
    [No Abstract] [Full Text] [Related]

  • 38. [A patient with severe hyperkalaemia -- an emergency after RALES].
    Nürnberger J, Daul A, Philipp T.
    Dtsch Med Wochenschr; 2005 Sep 09; 130(36):2008-11. PubMed ID: 16143930
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M.
    MMW Fortschr Med; 2002 Nov 28; 144(48):38-43. PubMed ID: 12532542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.